| Apr 30, 2012
| 5:35 PM
Los hombres con disfunción eréctil quizás no tengan que volver a hacer planes adelantados para tener relaciones sexuales, luego de que Vivus Inc. ganara la aprobación en Estados Unidos de su producto Avanafil, que viene a competir con Viagra, de Pfizer...
| Jun 13, 2011
| 3:01 AM
In 1980, I moved my family from Maryland to the White Mountain Apache Reservation in Arizona to work on an issue most people are not comfortable talking about — diarrhea. At the time, diarrhea, which is preventable and treatable, was rampantly...
| Jun 16, 2011
| 4:39 PM
Perhaps instead of fighting over how many merchants in town sell seashells, they should consider not selling them at all ("Fighting over some seashells," Dave Hansen column, June 2).
Yes, I know, they are big sellers, and make money for the merchants....
| Sep 13, 2011
| 8:24 AM
LONDON (Reuters) - Contrary to popular belief, intrauterine contraceptive devices might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease, according to the results of...
| Apr 4, 2012
| 1:56 PM
NEW YORK (Reuters Health) - People who've ever had genital warts may have a somewhat higher risk of several types of cancer — possibly including common skin cancers, a new study suggests.
The findings, reported in the Journal of Infectious...
| Apr 19, 2012
| 5:40 PM
Shares of Human Genome Sciences doubled in Thursday morning trading on news that a major British biopharmaceutical company offered to buy it for $2.6 billion, which the Rockville company rejected as too low.
Human Genome, which uses the human DNA...
| Jan 23, 2012
| 9:18 AM
NEW YORK (Reuters Health) - Young women on birth control pills tend to have less painful menstrual periods than those not on the contraceptives, a new study finds.
Swedish researchers found that of 2,100 women followed from age 19 to 24, those on the...
| Nov 24, 2011
| 12:41 PM
LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil.
The move underscores Gardasil's lead in a $1 billion-plus worldwide...
| Feb 1, 2012
| 1:52 PM
Upon learning they are pregnant, most women dutifully nix the alcohol, sushi and caffeine.
But what about antidepressants?
Headlines about the potential risks of antidepressants on a developing fetus, including miscarriage, premature birth and newborn...
| Feb 26, 2012
| 11:45 PM
NEW YORK (Reuters Health) - Boys 11 years and up should get Merck & Co's Gardasil vaccine to protect them against HPV infections, which can cause genital warts as well as oral, penile and anal cancers, the nation's largest group of pediatricians said...
| Sep 20, 2011
| 8:52 AM
ZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis.
Roche's T-DM1 and Novartis's Afinitor...